Sanofi-Aventis (France) Hunts for Consumer Deals Up to $15 Billion

Bookmark and Share

Bloomberg -- Sanofi-Aventis SA plans to stick to acquisitions of as much as $15 billion as the French drugmaker seeks to replace revenue that it’s losing to competition from generic medicines.

MORE ON THIS TOPIC